£20.94

Generic Drugs: The Pay-for-Delay Problem (Public Health in the 21st Century Series)

Price data last checked 17 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Cheaper than 73% of the days we've watched it. Below what most people pay.

£21 today · 30-day average £22 · all-time low £13

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days • 74 data points (No recent data available)

Historical
Generating forecast...
£35.06 £11.03 £16.27 £21.51 £26.76 £32.00 £37.25 20 March 2026 07 April 2026 25 April 2026 13 May 2026 01 June 2026

Price Distribution

Price distribution over 74 days • 7 price levels

Days at Price
Current Price
6 days 6 days 8 days 22 days · current 5 days 13 days 14 days 0 6 11 17 22 £13 £15 £18 £21 £30 £34 £35 Days at Price

Price Analysis

Most common price: £21 (22 days, 29.7%)

Price range: £13 - £35

Price levels: 7 different prices over 74 days

Description

Brand-name pharmaceutical companies can delay generic competition that lowers prices by agreeing to pay a generic competitor to hold its competing product off the market for a certain period of time. These so-called "pay-for-delay" agreements have arisen as part of patent litigation settlement agreements between brand-name and generic pharmaceutical companies. "Pay-for-delay" agreements are "win-win" for the companies: brand name pharmaceutical prices stay high, and the brand and generic share the benefits of the brand's monopoly profits. Consumers lose, however: they miss out on generic prices that can be as much as 90 percent less than brand prices. For example, brand-name medication that costs $300 per month, might be sold as a generic for as little as $30 per month. This book examines the "pay-for-delay' program and how drug company pay-offs cost consumers billions.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
16 February 2011
Listed Since
27 September 2010

Barcode

No barcode data available

Similar Products You Might Like

Pharmaceutical Industry Developments: Specialty Drugs, Coupons, Reverse Payments & Product Hopping (Pharmacology - Research, Safety Testing and Regulation)
78% match

Pharmaceutical Industry Developments: Specialty Drugs, Coupons, Reverse Payments & Product Hopping (Pharmacology - Research, Safety Testing and Regulation)

£114.99 03 Jun 2026
Medicare Part D & Prescription Drugs (Health Care Issues, Costs and Access)
77% match

Medicare Part D & Prescription Drugs (Health Care Issues, Costs and Access)

£72.81 16 Jun 2026
Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)
77% match

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

Springer

£91.42 31 May 2026
Are Chronic Degenerative Diseases Part of the Ageing Process?: Insights from Comparative Biology
77% match

Are Chronic Degenerative Diseases Part of the Ageing Process?: Insights from Comparative Biology

Nova Science Publishers Inc

£68.58 05 Jun 2026
Competition and Marketing Strategies in the Pharmaceutical Industry (RLE Marketing) (Routledge Library Editions: Marketing)
77% match

Competition and Marketing Strategies in the Pharmaceutical Industry (RLE Marketing) (Routledge Library Editions: Marketing)

Routledge

£49.04 01 Jun 2026
Ethics and the Pharmaceutical Industry
77% match

Ethics and the Pharmaceutical Industry

Cambridge University Press

£39.68 09 Jun 2026
Good Clinical Practices in Pharmaceuticals (Drugs and the Pharmaceutical Sciences)
76% match

Good Clinical Practices in Pharmaceuticals (Drugs and the Pharmaceutical Sciences)

CRC Press

£50.16 05 Jun 2026
Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)
76% match

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Routledge

£45.99 25 May 2026
Intellectual Property, Medicine and Health (Intellectual Property, Theory, Culture)
76% match

Intellectual Property, Medicine and Health (Intellectual Property, Theory, Culture)

Routledge

£43.90 05 Jun 2026
Clinical Genetics: Problems in Diagnosis and Counseling
76% match

Clinical Genetics: Problems in Diagnosis and Counseling

Academic Press

£43.99 09 Jun 2026
The Economics of Diseases and Cures (Economic Issues, Problems and Perspectives)
75% match

The Economics of Diseases and Cures (Economic Issues, Problems and Perspectives)

£203.99 07 Jun 2026
Public-Private Partnerships in Health: Improving Infrastructure and Technology
75% match

Public-Private Partnerships in Health: Improving Infrastructure and Technology

Springer

£38.63 27 May 2026
75% match

Smolen Controlled ∗drug∗ Bioavailability – Bioavailability Control By Drug Deliver: v. 3

Wiley-Blackwell

£94.50 05 Jun 2026
Managing Biotechnology: From Science to Market in the Digital Age
75% match

Managing Biotechnology: From Science to Market in the Digital Age

Wiley

£32.80 05 Jun 2026
PROPOFOL PHARMACOKINETICS MEDICAL US: Pharmacokinetics, Medical Uses & Potential Health Effects (Pharmacology-research, Safety Testing and Regulation)
75% match

PROPOFOL PHARMACOKINETICS MEDICAL US: Pharmacokinetics, Medical Uses & Potential Health Effects (Pharmacology-research, Safety Testing and Regulation)

Nova Science Publishers Inc

£57.99 09 Jun 2026
Education to Meet New Challenges in a Networked Society (Education in a Competitive & Globalizing World Series)
75% match

Education to Meet New Challenges in a Networked Society (Education in a Competitive & Globalizing World Series)

£42.56 08 Jun 2026
The Private Life of the Genome: Genetic Information and the Right to Privacy
75% match

The Private Life of the Genome: Genetic Information and the Right to Privacy

Routledge

£40.72 04 Jun 2026
Health Insurance Model for Analyzing Legislative Policy Options (Health Care Issues, Costs and Access Series)
75% match

Health Insurance Model for Analyzing Legislative Policy Options (Health Care Issues, Costs and Access Series)

£46.05 08 Jun 2026
Drug Design: Medicinal Chemistry: A Series of Monographs, Volume 8
75% match

Drug Design: Medicinal Chemistry: A Series of Monographs, Volume 8

Academic Press

£43.99 21 May 2026
General Botany
75% match

General Botany

Academic Press

£43.99 09 Jun 2026
COVID-19: Overview, Economic Implications and Federal Response (Public Health in the 21st Century)
75% match

COVID-19: Overview, Economic Implications and Federal Response (Public Health in the 21st Century)

£203.99 07 Jun 2026
Pharmacogenomics: A Primer for Clinicians
75% match

Pharmacogenomics: A Primer for Clinicians

McGraw-Hill Education

£66.19 16 May 2026
Cost-Contained Regulatory Compliance: For the Pharmaceutical, Biologics, and Medical Device Industries
74% match

Cost-Contained Regulatory Compliance: For the Pharmaceutical, Biologics, and Medical Device Industries

Wiley

£83.38 06 Jun 2026
Improving Healthcare: A Dose of Competition: 9 (Developments in Health Economics and Public Policy, 9)
74% match

Improving Healthcare: A Dose of Competition: 9 (Developments in Health Economics and Public Policy, 9)

Springer

£129.11 18 May 2026